Sign inGet started

Quan Lucinda Y.

Insider CIK 1824711 · ALGS See Remarks

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ALGS Aligos Therapeutics, Inc. A Award deriv2023-09-082023-09-1248,000— $048,000SEC↗
ALGS Aligos Therapeutics, Inc. A Award deriv2023-03-152023-03-1778,750— $078,750SEC↗
ALGS Aligos Therapeutics, Inc. A Award deriv2022-07-072022-07-1152,500— $052,500SEC↗
ALGS Aligos Therapeutics, Inc. A Award deriv2022-02-042022-02-0826,250— $026,250SEC↗
ALGS Aligos Therapeutics, Inc. A Award deriv2022-02-042022-02-08105,000— $0105,000SEC↗
ALGS Aligos Therapeutics, Inc. A Award deriv2020-12-012020-12-03200,000— $0200,000SEC↗
ALGS Aligos Therapeutics, Inc. C Conversion deriv2020-10-202020-10-206,835— $00SEC↗
ALGS Aligos Therapeutics, Inc. C Conversion deriv2020-10-202020-10-20726— $00SEC↗
ALGS Aligos Therapeutics, Inc. C Conversion deriv2020-10-202020-10-201,697— $00SEC↗
ALGS Aligos Therapeutics, Inc. C Conversion2020-10-202020-10-201,697— $08,532SEC↗
ALGS Aligos Therapeutics, Inc. C Conversion2020-10-202020-10-20726— $09,258SEC↗
ALGS Aligos Therapeutics, Inc. C Conversion2020-10-202020-10-206,835— $06,835SEC↗